|
|
The monitoring report and effect analysis on the adverse drug reaction promoted by the application of PDCA circulation in our hospital |
WEI Ling DAI Jing SHEN Dong-mei CAI Jie-qing |
Department of Pharmacy,the First People′s Hospital of Jiujiang County in Jiangxi Province,Jiujiang332000,China |
|
|
Abstract Objective To explore the effect of PDCA cycle management tool which continuously improves on the adverse drug reaction(ADR)report and surveillance and management of our hospital,the ADR reporting and the monitoring management standardizes,improving the quality of management,promoting the clinical rational administration.Methods Tapplication PDCA the problems existing in ADR surveillance of our hospital are analyzed and the reasons were found out by applying the 4 key steps in the PDCA cycle management(planning,implementation,inspection,and processing), The plan which was aimed at addressing the problem was formulated and implemented.Problems will be discovered during the repeated check process,and the management will be improved and enhanced to achieve the purpose of standardized management.Results After implementing PDCA cycle management,through establishing drug bad reaction monitoring and report work management system,taking effective measures,and implementing ADR report and monitoring, in 2015 the ADR reported total,and medical personnel reported volume,and records electronic medical record number, and reported department had respectively increased 558.0%,33.3%,and 1288.0%,and 200.0%in our hospital,effective intervention(P<0.05);the first medication easily occur ADR,the above reported constitute proportion had increased 116.4%,and 320.7%%in 1-3 days and 4-10 days,effective intervention(P<0.05);vein and oral medicine still far above other drug way,but lead to ADR proportion had declined 16.3%,effective intervention(P<0.05);anti-infection material lead to the ADR proportion had declined 63.6%,effective intervention(P<0.05);Chinese medicine injection agent cause that ADR proportion has increased 70.3%,there was no significant difference(P>0.05);the damage of skin and the annex organ was still the most,but cause that ADR proportion had declined 18.7%,there was no significant difference(P> 0.05),and had increased the report of liver,gall and gastrointestinal system and other serious ADR cases.Conclusion PDCA circulation management facilitates the management on ADR monitoring in our hospital.The management quality and level have achieved continuous improvement,promoting the safety and rationality of clinical drug use.
|
|
|
|
|
[1] |
Deming WE.The new economics:for industry,government and education[M].Cambridge MA:MIT CAES,1994:123.
|
[2] |
卫生部.关于印发《三级综合医院评审标准(2011年版)》实施细则[Z].[2011]33号,2011-12-26.
|
[3] |
魏玲,洪进德,吴琪,等.某院170例药品不良反应分析[J].医学信息,2014,8(27):175-176.
|
[4] |
国家药品不良反应监测中心.药品不良反应报告和监测工作手册[EB/OL].http://www.cdr.gov.cn/zscx/qtdzzl/index.shtml. 2010-01-24/2015-05-20.
|
[5] |
李季梅.加强管理提高药品不良反应报告数量和质量分析[J].首都医药,2013,6(12):37-39.
|
[6] |
唐莲,虞燕霞,周琴,等.PDCA循环管理方法在我院药品不良反应监测管理中的应用效果分析[J].中国药房,2015,26(28):4027-4029.
|
[7] |
陈光建,高阳.省级中心对基层药品不良反应监测绩效考核的实证分析[J].中国药物警戒,2010,7(6):349-352.
|
[8] |
董铎,刘巍,杨乐,等.欧盟药品不良反应管理和上报指南简介[J].中国药物警戒,2014,11(10):611-617.
|
[9] |
沈冬梅,代晶.我院药品不良反应监测与上报工作管理体系建立实践[J].江西医药,2015,12(24):33-36.
|
[10] |
缴万里,王云松,刘海净,等.药品不良反应报告分析与预防措施研究[J].中华医院感染学杂,2015,25(2):357-359.
|
[11] |
庄妹,庄将协,林翩翩.合理用药与药物不良事件的监测与探讨[J].海峡药学,2015,25(7):270-271.
|
[12] |
徐斌.浅谈药品的不良反应与合理用药[J].中国医药指南,2014,12(5):247-248.
|
[13] |
严美善.药品不良反应的特点与临床合理用药[J].中国医药指南,2013,11(35):90-91.
|
[14] |
刘春宇.药品不良反应和合理用药[J].北方药学,2015,12(12):117.
|
[15] |
罗应婷,杨钰娟.SPSS统计分析从基础到实践[M].2版.北京:电子工业出版社,2010.
|
|
|
|